跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Sobetirome
首页
药物
Sobetirome
Investigational
Small Molecule
Sobetirome
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
技术标识符
化学式
C
20
H
24
O
4
CAS 编号
211110-63-3
UNII ID
XQ31741E9Q
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
SOBETIROME IN THE TREATMENT OF MYELINATION DISEASES
EP 2991670 B8
申请人: UNIV OREGON HEALTH & SCIENCE
优先权: 2013
CN
EP
US
WO
7 件公开
PROCESS FOR THE PREPARATION OF DERIVATIVES OF SOBETIROME
EP 3936497 A1
申请人: UNIV OREGON HEALTH & SCIENCE
优先权: 2016
CN
EP
US
5 件公开
Derivatives of sobetirome
US 9701650 B2
申请人: UNIV OREGON HEALTH & SCIENCE
优先权: 2015
CN
US
4 件公开
US 11578032 B2
申请人: UNIV OREGON HEALTH & SCIENCE
优先权: 2018
CN
US
2 件公开
Use of GC-1 in transplant related population
US 10780069 B2
申请人: UNIV OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION
优先权: 2018
US
2 件公开
METHODS AND COMPOSITIONS FOR TREATING DEMYELINATING DISEASES USING SOBETIROME OR A SOBETIROME PRODRUG AND A PPAR ACTIVATOR
US 2018353450 A1
申请人: NEUROVIA INC
优先权: 2018
US
USE OF SOBETIROME AND PRODRUGS AND DERIVATIVES THEREOF FOR TREATING PITT-HOPKINS SYNDROME
US 20240307334 A1
申请人: LIEBER INST INC
优先权: 2024
US
药物
反馈